Navigation Links
European Society of Human Reproduction and Embryology Annual Meeting July 3-6, 2011, Stockholm
Date:6/1/2011

  • Free registration for bona fide media presenting official press credentials
  • Media centre with free computing, international phone & internet facilities & IT support
  • English, Swedish, Spanish, German, and French speaking press office staff [NB: The official conference language is English]

News briefings will be held:
09.45 hrs CEST Monday 4 July (Swedish)
11.45 hrs CEST Monday 4 July (English)
14.00 hrs CEST Monday (Fertility Europe English)
11.45 hrs CEST Tuesday 5 July (English)
17.00 hrs CEST Tuesday 5 July (English)
09.30 hrs CEST Wednesday 6 July (English)

Here are a few of the new results to be announced at the conference:

  • Can brushing your teeth regularly help you to become pregnant more quickly?
  • New, non-invasive test for chromosome abnormalities may also shed light on genetic origins of faulty eggs
  • How does socioeconomic class affect early fertility loss?
  • Researchers investigate whether aneuploid embryos can self-correct their abnormalities between day 3 and day 5
  • Recurrent miscarriage: how to help women with this condition become pregnant?
  • Large study in Nordic countries looks at stillbirth rates after ART. How do they compare to naturally conceived children?
  • How does neonatal outcome from babies born after frozen embryo transfer compare to fresh embryo transfer? Can frozen embryo transfer lead to Large Offspring Syndrome? Two studies from France and Denmark throw light on this issue
  • Large new study helps disentangle the relationship between maternal characteristics, IVF treatment methods and singleton IVF children
  • How many embryos to transfer? Swedish researchers develop new method to avoid twins while maintaining high live birth rates
  • Can stopping smoking before pregnancy help women conceive?
  • 20% of all pregnancies threaten to miscarry: now researchers have found a reliable way to predict which of these will miscarry, and therefore need targeted intervention, and which do not
  • The "vanishing twin" phenomenon: can it explain congenital abnormalities in babies born after infertility treatment?
  • Researchers explain the long-term impact of funding cuts for IVF in Denmark
  • Large study of outcomes after ICSI reveals factors that are most likely to affect chances of a live birth and risk of first trimester pregnancy loss
  • New association between mothers' height and IVF twinning found; could help develop personalised fertility treatment
  • Latest figures on the use of ART in Europe and across the world
  • New home ovulation test boosts chances of pregnancy

Registration

To register download the form at http://www.eshre.eu/binarydata.aspx?type=doc&sessionId=hdjttwf1axggcpesevbqgnvu/Media_Registration_Form[1].doc

and fax or email it with a scanned copy of your press credentials to:

Hanna Hanssen
ESHRE Communications Manager
Fax: +32 (0) 2 269 56 00
Tel: +32 (0) 2 269 09 69
Email: hanna@eshre.eu

For more information contact Hanna Hanssen or visit the ESHRE website at www.eshre.eu.

Registration in advance is recommended. You may register on site providing that you produce correct press credentials - an officially recognised press card and/or a commissioning letter from a recognised media organisation. Business cards are not acceptable.

Media Policy

Please note ESHRE's media policy for the conference:

http://www.eshre.eu/binarydata.aspx?type=doc&sessionId=flxxpmygqlcigwmg1anq1i55/Media_policy_ESHRE2010(1).pdf

Venue

The conference will take place at:

Stockholmsmssan AB
125 80 Stockholm
Sweden

Accommodation

Hotel rooms can be booked on the ESHRE website at https://b-com.mci-group.com/Registration/ESHRE2011.aspx


'/>"/>

Contact: Hanna Hanssen
hanna@eshre.eu
322-263-6466
European Society of Human Reproduction and Embryology
Source:Eurekalert

Related medicine news :

1. Your e-Marketing Journey in 2010: An e-Book for Corporate Communicators Working in European Headquarters
2. United Therapeutics Corporation Withdraws European Marketing Authorization Application for Tyvaso for the Treatment of Pulmonary Arterial Hypertension
3. International Collaboration: FDA and European Medicines Agency Agree to Accept a Single Orphan Drug Designation Annual Report
4. Yondelis(R) Receives Five New Approvals Outside the European Economic Area
5. Promega Maxwell 16 IVD System CE Marked to the European Union IVD Directive Delivers Combined Solution for Infectious Disease
6. The European Medicines Agency Completes Validation Stage for InterMunes Marketing Authorization Application for pirfenidone
7. European hematologist receives award to conduct research in US
8. European collaboration seeks to create World Wide Web for robots
9. HCL Thames Medics says more locum doctors could help address European Working Time Directive shortage
10. Third European Novel Food Approval Received by Tahitian Noni International
11. European Urology: Editorial about REDUCE trial underlines value of dutasteride
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: